BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34331162)

  • 1. Stepwise Limited Axillary Lymph Node Dissection Based on Lymphatic Drainage from the Breast to Decrease Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
    Yuan Q; Hou J; Zhou R; Zheng L; Lu F; Deng T; Zhou W; Wu G
    Ann Surg Oncol; 2022 Jan; 29(1):500-508. PubMed ID: 34331162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional axillary dissection based on lymphatic drainage for breast cancer: a single center randomized clinical trial].
    Yuan QQ; Hou JX; Zhou R; Zou SQ; Wu GS
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(32):2531-2536. PubMed ID: 34407579
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.
    Yuan Q; Wu G; Xiao SY; Hou J; Ren Y; Wang H; Wang K; Zhang D
    Ann Surg Oncol; 2019 Oct; 26(11):3446-3454. PubMed ID: 31240591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
    Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
    BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
    Nos C; Lesieur B; Clough KB; Lecuru F
    Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
    Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
    Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
    Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
    Trials; 2013 Apr; 14():111. PubMed ID: 23782712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N; Kuusk U; Wiseman SM
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.
    Bedrosian I; Babiera GV; Mittendorf EA; Kuerer HM; Pantoja L; Hunt KK; Krishnamurthy S; Meric-Bernstam F
    Cancer; 2010 Jun; 116(11):2543-8. PubMed ID: 20336790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
    Abdelhamid MI; Bari AA; Farid MI; Nour H
    Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].
    Gobardhan PD; Klompenhouwer EG; Beek MA; Voogd AC; Luiten EJ
    Ned Tijdschr Geneeskd; 2013; 157(22):A5646. PubMed ID: 23714290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
    Pavlista D; Eliška O
    Ceska Gynekol; 2012 Jun; 77(3):251-4. PubMed ID: 22779729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.